Past CTSI Pilot Awardee Lands in PLOS ONE’s Top 25%
A UR CTSI-funded bladder cancer study is among the 25 percent most cited studies published in PLOS ONE in 2016. The study offers a biomarker and drug target candidate for bladder cancer, the fifth most common cancer.
CTSI Faculty Pilot Project Identifies New Hearing Test for Autism Risk
Research partially supported by a CTSI Faculty Pilot award may offer a new way to screen very young children for Autism. The study shows that children with Autism may have inner ear deficiencies that impact their ability to recognize speech.
1
2